Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion description "[We have previously reported that systemic blockade of IL-1beta in patients with type 2 diabetes with anakinra (a recombinant human interleukin-1-receptor antagonist, IL-1Ra), lowered glycated hemoglobin improved beta-cell function and reduced circulating levels of IL-6 and CRP (7).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion evidence source_evidence_literature NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion SIO_000772 19541594 NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion wasDerivedFrom befree-20140225 NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_assertion wasGeneratedBy ECO_0000203 NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP659646.RAcZ_pUbq5S8EwqqD2fvq4935d4fUV239zy1bvQ0ChXdE130_provenance.